Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2022-01-31 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2022-01-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31.12.2021. It is a certification from the registrar and share transfer agents confirming that details of securities dematerialized/rematerialized have been furnished to stock exchanges. The document is short (3754 characters) and primarily a certification letter rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2022-01-13 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (118 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report content, or detailed information. Given the lack of content, this cannot be classified as a full report or detailed filing. It is most consistent with a Report Publication Announcement (RPA) or Regulatory Filing (RNS) due to its brevity and lack of detail. Since there is no explicit mention of a report being attached or published, and no regulatory or certification language, the fallback category Regulatory Filings (RNS) is appropriate.
2021-12-29 English
Shareholders meeting
Regulatory Filings
2021-12-28 English
Demise
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the sad demise of a Whole-time Director of the company. It includes details required under Regulation 30 of SEBI Listing Regulations and SEBI Circular CIR/CFD/CMD4/2015, which pertains to disclosure of material events including changes in directors. The content is an announcement of a change in the company's board of directors due to death, not a report or financial statement. The document length is about 11,666 characters, but the content is clearly an announcement of a board/management change. Therefore, the appropriate classification is Board/Management Information (MANG).
2021-11-29 English
Reply to Clarification- Financial results
Annual Report Classification · 95% confidence The document is a detailed communication addressed to stock exchanges (BSE and NSE) regarding the outcome of an adjourned Board meeting held on 09.07.2021. It specifically mentions the approval of audited financial results for the quarter and year ended 31.03.2021, and the auditors' report along with a declaration as per SEBI regulations. The document includes detailed financial statements such as the Profit and Loss statement for the quarter and year ended 31 March 2021, with extensive financial data and analysis. This indicates it is a comprehensive financial report for a full fiscal year, not just a brief announcement or certification. The presence of audited financial results and auditors' report for the year ended 31.03.2021 strongly suggests this is an Annual Report or equivalent annual financial filing. Given the detailed financial data and the annual period covered, the most appropriate classification is Annual Report (10-K).
2021-11-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.